|
Build Your Online Product Catalogs?
Product Name: |
Pentapeptide-3/Pentapeptide-3
|
Supply Ability: |
5000g |
Related proudcts |
56-81-5, pentapeptide, |
Specifications |
1g,10g,100g,1000g |
Price Term: |
FOB |
Port of loading: |
Chengdu |
Minimum Order |
1g |
Unit Price: |
1000 |
|
Pentapeptide-3 1.Basic information: INCI Name: Pentapeptide-3 Reference: Vialox Cas No: 725232-44-0,135679-88-8 Formula: C21H37N9O5 Molecular: 495.58 Sequence: H-Gly-Pro-Arg-Pro-Ala-NH2 Purity: 95% Appearance: white powder Odor: no Stability: stable Solubility: soluble in water Source: synthetic Formulation: available for your reference, please contact us MSDS and COA: available for your reference, please contact us Capacity: 500g per month
2.Usage: face cream and anti wrinkles creams to treat crows feet and wrinkles
3.Functions: 1. Pentapeptide-3 Reduce the depth of expression wrinkles, especially in the forehead and around eyes 2. Pentapeptide-3 Target the wrinkle formation mechanism of expression wrinkles in a new way, offering a alternative or complement to peptides like acetyl-hexapeptide-3.
4.Description: Pentapeptide-3 is an anti-wrinkle ingredient that is very potent. It is found in the form of a powder kit and has been proven to reduce wrinkling by 49%. It works by reducing the contraction of muscle cells. It is widely known to be similar to Botox, but is a topical cream, not an injection, making it attractive to those who do not like the idea of injections on their face.
The use of Pentapeptide-3 can exhibit a Botox-like reduction in wrinkles. Used twice a day, for 28 days, volunteers using Pentapeptide-3 in clinical studies applied the substance on half the face. The subjects were women who were between the ages of thirty and sixty. The primary use of Pentapeptide-3 was for the decrease in Crow¡¯s feet wrinkles, but it has now been found to be effect on other facial wrinkle. |
Company: |
Chengdu Youngshe Chemical Co.,Ltd
|
Contact: |
Ms. Zoe Yuan |
Address: |
TImu str77 |
Postcode: |
610000 |
Tel: |
8617711399154 |
Fax: |
|
E-mail: |
|
|
|
|